WIRB-Copernicus Group IRB Experts to Present at 2014 MAGI West Conference
Sessions will discuss how to work efficiently with IRBs, address human subject protections issues, and propose IRB best practices
PRINCETON, N.J., Nov. 10, 2014 – WIRB-Copernicus Group (WCG), the world’s largest provider of regulatory and ethical review services and software to support clinical research, announced today that four of its institutional review board (IRB) experts will be presenting at the MAGI West Conference being held Nov. 9-12 in San Francisco, Calif.
On the opening day of the conference (Nov. 9 from 5:15-6:15 p.m. PST), Troy Brinkman, JD, MA, CIP, WCG’s senior associate director of institutions, and Rebecca Clark, BBA, institutional IRB specialist at WCG’s Aspire IRB, will present “IRB Best Practices” with Parker Nolen, the manager of the IRB at Community Health Network. During this session, the speakers will present three innovative practices for improving human subject protection and increasing efficiencies within the clinical trial realm.
“Due to the ever-changing clinical research landscape, it is imperative that we create efficiencies and innovative processes that assist in advancing the protection of research subjects,” said Mr. Brinkman. “This seminar will empower participants to make distinctive, substantial and lasting improvements in the performance of their clinical trials.”
During the workshop on “Emerging Issues in Human Subjects Protection,” WCG Chief Compliance Officer David Forster, JD, MA, CIP, will highlight unsolved problems in the clinical research sector – relating to human subject protection – and suggest techniques to overcome these issues. This session will be held from 10:30-11:15 a.m. PST on Nov. 10.
WCG Vice President of Global Consulting Jeffrey A. Cooper, MD, MMM, will discuss how to work efficiently with IRBs, together with Robert Romanchuk, a member of Schulman Associates IRB, in the session entitled, “Navigating the IRB Process.” This session will be held from Nov. 11 at 2:45- 3:30 p.m. PST on Nov.11.
In addition, two WCG companies are sponsors and exhibitors at this year’s conference – Aspire IRB and ePharmaSolutions. Attendees will be able to see demonstrations of ePharmaSolutions’ SitePortal™, its new fully-validated, cloud-based clinical trial portal for sites, during the show.
For more information on the MAGI West Conference, please visit https://magiworld.org.
About The WIRB-‐Copernicus Group
The WIRB-Copernicus Group (WCG) is the world’s largest and most trusted provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG’s solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials.
WCG is proud to serve the individuals on the frontlines of science and medicine, and the organizations that strive to develop new products and therapies to improve the quality of human health. It is our role to empower them to accelerate advancement, while ensuring that the risks of progress never outweigh the value of human life.
For more information, please visit www.wcgclinical.com.
Download the Press Release